Massive ascites in pulmonary arterial hypertension: caution with epoprostenol

Ann Am Thorac Soc. 2013 Dec;10(6):726-7. doi: 10.1513/AnnalsATS.201305-115LE.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antihypertensive Agents / adverse effects*
  • Ascites / etiology*
  • Cardiac Output, High / chemically induced*
  • Epoprostenol / adverse effects*
  • Familial Primary Pulmonary Hypertension
  • Female
  • Heart Failure / chemically induced*
  • Humans
  • Hypertension, Pulmonary / drug therapy*

Substances

  • Antihypertensive Agents
  • Epoprostenol